Deep Track Capital, LP 13D and 13G filings for Magenta Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 08:47 am Sale |
2022-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
Deep Track Capital, LP | 3,000,000 4.950% |
-1,870,000 (-38.40%) |
Filing |
| 2022-02-14 08:58 am Purchase |
2021-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
Deep Track Capital, LP | 4,870,000 8.290% |
714,445 (+17.19%) |
Filing |
| 2021-05-14 4:05 pm Purchase |
2021-05-14 | 13G | Magenta Therapeutics, Inc. MGTA |
Deep Track Capital, LP | 4,155,555 7.140% |
4,155,555 (New Position) |
Filing |